Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
J Mater Sci Mater Med ; 21(7): 2243-51, 2010 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-20411308

RESUMEN

High molecular weight alginate beads with 59% mannuronic acid content or 68% guluronic acid were prepared using a droplet generator and crosslinked in calcium chloride. The alginate beads were compared to current embolisation microspheres for compressibility and monitored over 12 weeks for size and weight change at 37 degrees C in low volumes of ringers solutions. A sheep uterine model was used to analyse bead degradation and inflammatory response over 12 weeks. Both the in vitro and in vivo data show good delivery, with a compressibility similar to current embolic beads. In vitro, swelling was noted almost immediately and after 12 weeks the first signs of degradation were noted. No difference was noted in vivo. This study has shown that high molecular weight alginate gel beads were well tolerated by the body, but beads associated with induced thrombi were susceptible to inflammatory cell infiltration. The beads were shown to be easy to handle and were still observable after 3 months in vivo. The beads were robust enough to be delivered through a 2.7 Fr microcatheter. This study has demonstrated that high molecular weight, high purity alginate bead can be considered as semi-permanent embolisation beads, with the potential to bioresorb over time.


Asunto(s)
Alginatos/química , Embolización Terapéutica , Ácidos Hexurónicos/química , Cloruro de Calcio/química , Formas de Dosificación , Geles , Ácido Glucurónico/química , Microesferas
2.
BMC Musculoskelet Disord ; 10: 164, 2009 Dec 22.
Artículo en Inglés | MEDLINE | ID: mdl-20028538

RESUMEN

BACKGROUND: The purpose of this study was to evaluate the performance a newly developed nanocrystalline hydroxyapatite, OSTIM following functional implantation in femoral sites in thirty-eight sheep for 1, 2 or 3 months. Ostim 35 was compared to an established calcium phosphate, Alpha BSM. METHODS: Biomechanical testing, micro-CT analysis, histological and histomorphological analyses were conducted to compare the treatments including evaluation of bone regeneration level, material degradation, implant biomechanical characteristics. RESULTS: The micro-computed tomography (microCT) analysis and macroscopic observations showed that Ostim seemed to diffuse easily particularly when the defects were created in a cancellous bone area. Alpha BSM remained in the defect.The performance of Ostim was good in terms of mechanical properties that were similar to Alpha BSM and the histological analysis showed that the bone regeneration was better with Ostim than with Alpha BSM. The histomorphometric analysis confirmed the qualitative analysis and showed more bone ingrowth inside the implanted material with Ostim when compared to Alpha BSM at all time points. CONCLUSIONS: The successful bone healing with osseous consolidation verifies the importance of the nanocrystalline hydroxyapatite in the treatment of metaphyseal osseous volume defects in the metaphyseal spongiosa.


Asunto(s)
Implantes Absorbibles/tendencias , Cementos para Huesos/farmacología , Enfermedades Óseas/tratamiento farmacológico , Regeneración Ósea/efectos de los fármacos , Durapatita/farmacología , Cicatrización de Heridas/efectos de los fármacos , Animales , Cementos para Huesos/uso terapéutico , Enfermedades Óseas/diagnóstico por imagen , Enfermedades Óseas/cirugía , Regeneración Ósea/fisiología , Modelos Animales de Enfermedad , Durapatita/uso terapéutico , Femenino , Nanopartículas/uso terapéutico , Evaluación de Resultado en la Atención de Salud , Oveja Doméstica , Resultado del Tratamiento , Cicatrización de Heridas/fisiología , Microtomografía por Rayos X
3.
Biomed Mater ; 13(3): 035010, 2018 03 14.
Artículo en Inglés | MEDLINE | ID: mdl-29359708

RESUMEN

The paradigm shift brought about by the expansion of tissue engineering and regenerative medicine away from the use of biomaterials, currently questions the value of histopathologic methods in the evaluation of biological changes. To date, the available tools of evaluation are not fully consistent and satisfactory for these advanced therapies. We have developed a new, simple and inexpensive quantitative digital approach that provides key metrics for structural and compositional characterization of the regenerated tissues. For example, metrics provide the tissue ingrowth rate (TIR) which integrates two separate indicators; the cell ingrowth rate (CIR) and the total collagen content (TCC) as featured in the equation, TIR% = CIR% + TCC%. Moreover a subset of quantitative indicators describing the directional organization of the collagen (relating structure and mechanical function of tissues), the ratio of collagen I to collagen III (remodeling quality) and the optical anisotropy property of the collagen (maturity indicator) was automatically assessed as well. Using an image analyzer, all metrics were extracted from only two serial sections stained with either Feulgen & Rossenbeck (cell specific) or Picrosirius Red F3BA (collagen specific). To validate this new procedure, three-dimensional (3D) scaffolds were intraperitoneally implanted in healthy and in diabetic rats. It was hypothesized that quantitatively, the healing tissue would be significantly delayed and of poor quality in diabetic rats in comparison to healthy rats. In addition, a chemically modified 3D scaffold was similarly implanted in a third group of healthy rats with the assumption that modulation of the ingrown tissue would be quantitatively present in comparison to the 3D scaffold-healthy group. After 21 days of implantation, both hypotheses were verified by use of this novel computerized approach. When the two methods were run in parallel, the quantitative results revealed fine details and differences not detected by the semi-quantitative assessment, demonstrating the importance of quantitative analysis in the performance evaluation of soft tissue healing. This automated and supervised method reduced operator dependency and proved to be simple, sensitive, cost-effective and time-effective. It supports objective therapeutic comparisons and helps to elucidate regeneration and the dynamics of a functional tissue.


Asunto(s)
Materiales Biocompatibles/química , Colágeno/química , Ingeniería de Tejidos/métodos , Cicatrización de Heridas , Algoritmos , Animales , Anisotropía , Diabetes Mellitus/terapia , Fibroblastos/metabolismo , Fibrosis , Masculino , Ratas , Ratas Sprague-Dawley , Andamios del Tejido/química
4.
J R Soc Interface ; 3(11): 767-75, 2006 Dec 22.
Artículo en Inglés | MEDLINE | ID: mdl-17015296

RESUMEN

In order to study the pathobiological impact of the nanometre-scale of materials, we evaluated the effects of five different materials as nanoparticulate biomaterials in comparison with bulk samples in contact with living tissues. Five groups out of 10 rats were implanted bilaterally for up to 12 months with materials of the same type, namely TiO2, SiO2, Ni, Co and polyvinyl chloride (PVC), subcutaneously with bulk material on one side of the vertebral column and intramuscularly with nanoparticulate material on the contralateral side. At the end of each implantation time, the site was macroscopically examined, followed by histological processing according to standard techniques. Malignant mesenchymal tumours (pleomorphic sarcomas) were obtained in five out of six cases of implanted Co nanoparticle sites, while a preneoplastic lesion was observed in an animal implanted with Co in bulk form. In the Ni group, all animals rapidly developed visible nodules at the implanted sites between 4 and 6 months, which were diagnosed as rhabdomyosarcomas. Since the ratio of surface area to volume did not show significant differences between the Ni/Co group and the TiO2/SiO2/PVC group, we suggested that the induction of neoplasia was not mediated by physical effects, but was mediated by the well-known carcinogenic impact of Ni and Co. The data from the Co group show that the physical properties (particulate versus bulk form) could have a significant influence on the acceleration of the neoplastic process.


Asunto(s)
Materiales Biocompatibles/efectos adversos , Nanopartículas del Metal/efectos adversos , Sarcoma/etiología , Animales , Cobalto/efectos adversos , Ensayo de Materiales , Níquel/efectos adversos , Cloruro de Polivinilo/efectos adversos , Ratas , Sarcoma/patología , Dióxido de Silicio/efectos adversos , Neoplasias Cutáneas/etiología , Neoplasias Cutáneas/patología , Titanio/efectos adversos
5.
Microsc Res Tech ; 78(10): 900-7, 2015 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-26238067

RESUMEN

Previous articles have pointed out the presence of type III collagen within the extracellular structure of the parenchymatous organs. This study aimed to quantitatively characterize the collagen polymorphism at the capsule and parenchymal trabeculae of the largest lymphoid organ of the body i.e., the spleen, in mouse, rat, and rabbit models. Following a Picrosirius Red-Polarization procedure and computer assisted image analysis of paraffin sections, the results showed (1) a predominant and significantly higher amount of type III collagen in the trabeculae area compared to the capsule area in the three species, (2) no statistical difference among the three species concerning the parenchymal collagen polymorphism or the type I/type III collagen ratio, (3) a heterogeneous type I/type III collagen ratio varying from 0.86 (mouse) to 6.62 (rabbit) in the fibromuscular capsule region. A qualitative analysis corroborated these histomorphometric results. In conclusion, the spleen may be used as (1) a control tissue to qualitatively visualize type I and III collagen under polarization microscopy and to validate the quality of PSR staining (2) an aid to accurately calibrate the angle of polarization before quantitative measurements of type I and type III collagen. Among the studied species, the rabbit spleen appeared to be the most appropriate control tissue as it showed the highest amount of type I collagen in the capsule and a similarly high amount of type III collagen in the parenchymal trabeculae.


Asunto(s)
Colágeno/análisis , Microscopía de Polarización/métodos , Microscopía de Polarización/normas , Patología/métodos , Bazo/química , Animales , Biometría/métodos , Ratones , Conejos , Ratas
6.
J Neurosurg ; 97(1 Suppl): 69-74, 2002 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-12120654

RESUMEN

OBJECT: The authors investigated the effect of a collagen-based sealant, Gel Amidon Oxydé (GAO), in preventing the reformation of epidural scar adhesions in an adult rat model of laminectomy. METHODS: Thirty-two adult Sprague-Dawley rats underwent a complete L5-6 laminectomy, after which the dura mater was exposed and the left adjacent L-4 and L-5 nerve roots were exposed. The surgical wound was then closed; 1 month later it was reopened. The epidural scar adhesions that developed were observed and carefully removed, leaving clean dura and nerve roots reexposed. In 16 experimental rats, GAO was placed onto the reexposed dura and around the nerve roots before it polymerized. No treatment was performed in 16 control rats. Postoperatively, all rats were healthy and without neurological deficit. The incisions healed within 1 week regardless of the treatment with the GAO. Three months after reoperation, magnetic resonance imaging revealed that important epidural adhesions were present in the control rats but not in the experimental rats. These findings were then confirmed by gross anatomical examination in which a white tissue layer was found over the dura without adhesions in the experimental animals, whereas significant epidural scar adhesions were demonstrated in the controls. Histological evaluation of the laminectomy site also showed that the peridural space in the experimental rats was larger than that in the controls. CONCLUSIONS: The authors found that GAO may be a safe and effective antiscarring adhesion biomaterial in vivo. When placed into the laminectomy site, GAO may prove beneficial in preventing the formation and reformation of epidural scar adhesions in humans.


Asunto(s)
Materiales Biocompatibles/uso terapéutico , Cicatriz/tratamiento farmacológico , Colágeno/uso terapéutico , Espacio Epidural , Laminectomía/efectos adversos , Enfermedades de la Columna Vertebral/tratamiento farmacológico , Adherencias Tisulares/prevención & control , Animales , Cicatriz/diagnóstico , Cicatriz/etiología , Cicatriz/patología , Espacio Epidural/patología , Imagen por Resonancia Magnética , Ratas , Ratas Sprague-Dawley , Prevención Secundaria , Enfermedades de la Columna Vertebral/diagnóstico , Enfermedades de la Columna Vertebral/etiología , Enfermedades de la Columna Vertebral/patología , Adherencias Tisulares/diagnóstico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA